Home » Topics » Regulatory » Patents

Patents
RSS

Phthalazine AMPA receptor antagonists claimed by Schering AG

Jan. 15, 1998

Prodrugs of COX-2 inhibitors prepared at Searle

Jan. 15, 1998

Lilly describes new glycopeptides active against VRE

Jan. 15, 1998

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Texas Biotechnology prepares new endothelin modulators

Jan. 15, 1998

New class of glucocorticoids with an improved pharmacological profile

Jan. 15, 1998

Agents with affinity for 5-HT2 receptors under development at Janssen

Jan. 14, 1998

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Novel ET antagonists claimed by BASF

Jan. 14, 1998

Serotonergic agents prepared at Merck KGaA as potential antidepressants/anxiolytics

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...